MERS-CoV spike nanoparticles protect mice from MERS-CoV infection

The Middle East respiratory syndrome coronavirus (MERS-CoV) was first discovered in late 2012 and has gone on to cause over 1800 infections and 650 deaths. There are currently no approved therapeutics or vaccinations for MERS-CoV. The MERS-CoV spike (S) protein is responsible for receptor binding an...

Descripción completa

Detalles Bibliográficos
Autores principales: Coleman, Christopher M., Venkataraman, Thiagarajan, Liu, Ye V., Glenn, Gregory M., Smith, Gale E., Flyer, David C., Frieman, Matthew B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423355/
https://www.ncbi.nlm.nih.gov/pubmed/28237499
http://dx.doi.org/10.1016/j.vaccine.2017.02.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423355/
https://www.ncbi.nlm.nih.gov/pubmed/28237499
http://dx.doi.org/10.1016/j.vaccine.2017.02.012

Ejemplares similares